approval
saveBKEMV (ECULIZUMAB-AEEB) — FDA approval
community read0 votes
Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 7mo ago
Found something off?
drug timeline · 6
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalMar 26, 2026 · 242d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalNov 24, 2025 · 364d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalSep 17, 2025 · 432d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalApr 18, 2025 · 584d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalOct 23, 2024 · 761d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalMay 28, 2024 · 909d ago
same company · ±60 days · 5
- approvalWEZLANA: WEZLANA (USTEKINUMAB-AUUB) — FDA approvalDec 26, 2024
- approvalWEZLANA: WEZLANA (USTEKINUMAB-AUUB) — FDA approvalDec 26, 2024
- approvalblinatumomab: BLINCYTO (BLINATUMOMAB) — FDA approvalDec 17, 2024
- recallAmgen, Inc. recall (Cls II)Mar 26, 2025
- recallAmgen, Inc. recall (Cls II)Mar 26, 2025
comments(0)
5-min edit window · permanent after that